Sector Overview Continuing the Innovation Journey Throughout the Lifecycle was the title of the fifth biennial PCI conference, held in Cork in September 2015.
CONTINUING THE INNOVATION JOURNEY THROUGHOUT THE LIFECYCLE
ifth Biennial PharmaChemical Ireland/PDA/ISPE Quality and Innovation Conference 3 & 24 September 2015 Radisson Little Island, Cork
association with
DRIVING THE INDUSTRY FORWARD
Fifth Biennial PharmaChemical Ireland/PDA/ISPE Quality and Innovation Conference 23 & 24 September 2015 Radisson Little Island, Cork
ponsored by In association with
Sponsored by
4 6
contribution that the sector makes to the economy here and also its central role in enhancing people’s lives from now into the future. In recognising the need to promote and support the establishment of a strong industry cluster in the country, the Board has supported opening up the membership of PCI to associate members. The primary purpose of it is to reach out to the industry’s partners and stakeholders in a more structured and inclusive way, with a view to enhancing the depth and scope of the sector here. PCI is also very keen to support the growth of indigenous companies here, both in Biopharma and chemical manufacture, as well as supply to the sector through products and services. Those interested in hearing more about this should contact me.
PCI Conference: Continuing the Innovation Journey Throughout the Lifecycle In September of this year, PCI hosted its fifth biennial conference in collaboration with The Parenteral Drugs Association (PDA) and the International Pharmaceutical Engineers (ISPE) in Cork. The title of the conference was ‘Continuing the Innovation Journey Throughout the Lifecycle’ and the event attracted 200 delegates from Ireland and overseas. The conference was addressed by an impressive range of national and international speakers drawn from the regulatory bodies and the industry. As ever, the HPRA provided excellent support for the event and the industry appreciated the opportunity to interact directly with the regulator. Delegates were briefed on the latest ICH Guide, Q12 that deals directly with Lifecycle Management, by the guide rapporteur, Moheb Nasr of GSK. The range of topics addressed was as broad as ever, from Tim O’Brien describing Mensenchymal Stem Cell Manufacture, through the latest trends from the FDA to a Kaizen Workshop hosted by Richard Keegan of Enterprise Ireland. Delegates were able to join a number of exhibitors for networking and knowledge sharing right the way through the event. Delegate feedback was very positive. Thanks to conference sponsors, Hovione, Indaver, MSD and Life Sciences Consultants. In conclusion, this has been a very busy period for the industry and for PCI. It is likely that this will continue for the foreseeable future as we grapple with the challenges that rapid growth present. However, I am confident that we can and we will meet these challenges now and into the future.
Irish PharmaChem | Industry Buyers Guide 2016